Health
No benefit from virus blood plasma: study – The West Australian
A trial looking at whether blood plasma from COVID-19 patients can help those who are seriously ill does not appear to work in ICU patients, researchers say.
An international trial testing convalescent blood plasma on COVID-19 patients with moderate and severe illness has halted enrolment of severely ill COVID-19 patients requiring intensive care after it found no benefit, trial investigators say.
The decision by the REMAP-CAP trial leaders came after an initial analysis of more than 900 severely ill trial participants in intensive care showed that treatment with the product – an antibody-rich plasma taken from people who have recovered from the pandemic…
-
General17 hours agoMelbourne lawyer fled Australia with $1.2m after filing for bankruptcy, court case alleges
-
Noosa News18 hours agoWounding investigation, Mooloolaba – Sunshine Coast
-
Noosa News13 hours agoMaroons name Gehamat Shibasaki for State of Origin debut against Blues, Josh Papali’i returns
-
Business14 hours agoCan the Xero share price deliver a 17% return after the US acquisition?